In ALK-rearranged NSCLC, fusion proteins such as EML4-ALK promote continuous activation of downstream signaling pathways including MAPK, PI3K-AKT-mTOR, and JAK-STAT leading to uncontrolled cell proliferation. Here, EML4 is linked to non-small cell lung carcinoma.